EurekaMag.com logo
+ Translate

Biology, Geography & Health: Chapter 6096


Chapter 6096 provides bibliographic information on scholary research in the basic and applied life, earth and health sciences.


Namba, T.; Komatsu, K.; Mikage, M., 1986: Pharmacognostical studies on the chinese crude drug fu pen zi 3. botanical origin of fu pen zi from korea ii

Mikage M., 1987: Pharmacognostical studies on the chinese crude drug fu pen zi 5 botanical origin of fu pen zi from china mainland

Taki, K.; Yamazaki, F.; Mizuno, M.; Kubo, M., 1977: Pharmacognostical studies on the chinese crude drug gehua part 2 on the morphology of the pollen grains

Namba, T.; Takano, A.; Komatsu, K.; Mikage, M., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 1. the plant origin of pu gong ying from taiwan

Namba, T.; Takano, A.; Mikage, M., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 2. the plant origin of pu gong ying from taiwan

Namba, T.; Takano, A.; Mikage, M., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 3. on the general structure of underground parts of taraxacum plants and the botanical origin of hokoei from shikoku district japan


Takano, A.; Mikage, M.; Namba, T., 1987: Pharmacognostical studies on the chinese crude drug pu gong ying 4. on the botanical origin of hokoei from nagano and gunma prefectures japan

Ota, N.; Mino, Y.; Tanaka, K., 1982: Pharmacognostical studies on the chinese crude drug sophorae radix 2. on the crude drug sophorae radix from japan korea and china

Namba, T.; Kubo, M.; Mikage, M., 1976: Pharmacognostical studies on the chinese crude drug xia ku cao

Inagaki, K.; Nunome, S.; Namba, T., 1983: Pharmacognostical studies on the chinese crude drugs derived from insects 2. banmao

Namba, T.; Inagaki, K.; Nunome, S., 1983: Pharmacognostical studies on the chinese crude drugs derived from insects 3. hongniangzi

Nakamura H., 1982: Pharmacognostical studies on the chinese crude drugs derived from insects on mengchong

Namba, T.; Mikage, M.; Komatsu, K., 1982: Pharmacognostical studies on the chinese crude drugs di fu zi and chong wei zi 1. the crude drugs derived from leonurus

Kubo, M.; Katsuki, T.; Nagao, T.; Mizuno, M.; Ohashi, H., 1977: Pharmacognostical studies on the chinese crude drugs gehua

Xie Z., 1987: Pharmacognostical studies on the chinese drug guanzhong produced in middle south china

Namba, T.; Mikage, M.; Komatsu, K.; Xu, L. S.; Xu, G. J., 1988: Pharmacognostical studies on the chinese drug jinyinhua iii. botanical origins of well circulating drug in china mainland

Shimomura, H.; Sashida, Y.; Takagishi, T.; Terakado, H., 1982: Pharmacognostical studies on the crude drug bai he 1. comparative studies on external structures

Shimomura, H.; Sashida, Y.; Takagishi, T.; Kishimoto, A.; Furuuchi, N., 1984: Pharmacognostical studies on the crude drug bai he 2. the characteristics of the internal structures

Okuno, I.; Okanishi, T.; Noro, Y.; Namba, T., 1980: Pharmacognostical studies on the crude drug inchinko in japan 4. capitulum of artemisia japonica and artemisia japonica ssp littoricola

Namba, T.; Okuno, I.; Noro, Y., 1982: Pharmacognostical studies on the crude drug inchinko in japan 5. morphological studies on the flower heads of japanese artemisia

Okuno, I.; Kagawa, K.; Noro, Y.; Namba, T., 1983: Pharmacognostical studies on the crude drug inchinko in japan 6. seasonal variation in chemical constituents of artemisia capillaris

Yamagata, E.; Yoneda, K., 1987: Pharmacognostical studies on the crude drug of agarwood vi. on kanankoh

Namba, T.; Bae, K. H.; Akai, K., 1980: Pharmacognostical studies on the crude drug zhu ye and bambusaceous plants 1. the crude drug dan zhu ye from china

Namba, T.; Bae, K., 1984: Pharmacognostical studies on the crude drug zhu ye and bambusaceous plants 9. keys for identification of the leaves of bambusaceous plants based on the anatomical characteristics

Namba, T.; Bae, K. H., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 2. on the botanical origins of the crude drug wa no tan chiku yo on the japanese markets and the crude drug juk yeup on the korean markets and the comparative anatomical studies on the leaves of the genus phyllostachys

Namba T., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 3 botanical origins of the crude drug juk yeup on the korean markets and the comparative anatomical studies of the leaves of the genera sasamorpha and pseudosasa

Bae, K. H.; Namba, T., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 4. botanical origins of the crude drug juk yeup on the korean markets and the comparative anatomical studies of the leaves of the genus pleioblastus

Namba, T.; Bae, K. H., 1982: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 4. the comparative anatomical studies on the leaves of the genera bambusa and dendrocalamus

Namba, T.; Bae, K. H., 1981: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 5. the comparative anatomical studies on the leaves of the genera semiarundinaria sinobambusa shibataea tetragonocalamus and chimonobambusa

Namba, T.; Bae, K. H., 1982: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 7. the botanical origins of the folk medicine kuma zasa on the japanese markets and the comparative anatomical studies of the leaves of the genus sasa sections sasa macrochlamys monilicladae and lasioderma

Bae, K. H.; Namba, T., 1982: Pharmacognostical studies on the crude drug zhu ye and the bambusaceous plants 8. the internal and surface structures of the leaves of the genus sasaella and the section crassinodi of the genus sasa

Namba, T.; Lin, C. C.; Kikuchi, T.; Kan, W. S., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 1. i tiam hong

Lin, C. C.; Namba, T., 1982: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 10. on koan lan hioh

Namba, T.; Lin, C. C.; Kan, W. S., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 2. i tiam hong

Namba, T.; Lin, C. C.; Kan, W. S., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 3. i tiam hong

Namba, T.; Lin, C. C., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 4. chioh hak 1

Namba, T.; Lin, C. C., 1981: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 5. chioh hak 2

Lin, C. C.; Namba, T., 1982: Pharmacognostical studies on the crude drugs of orchidaceae from taiwan 9. chheng thian liong thiau

Okada, M., 1976: Pharmacognostical studies on the genus rhamnus

Taki, K.; Yamazaki, F.; Mizuno, M., 1976: Pharmacognostical studies on the market articles hoo at hong kong

Konoshima, M.; Miyagawa, T., 1976: Pharmacognostical studies on the piperaceous plants 2 studies on the crude drugs of stems part 2 on the piper eupiper and cubeba sections and peperomia

Konoshima, M.; Miyagawa, T., 1976: Pharmacognostical studies on the piperaceous plants part 1 studies on the crude drugs of stems part 1 on the piper chavica section

Konoshima, M.; Miyagawa, T., 1977: Pharmacognostical studies on the piperaceous plants part 3 studies on the crude drugs of leaves

Kong Y.C., 1985: Pharmacognostical studies on the related articles of kudingcha in hong kong market

Mary, Z.; Yoganarasimhan, S. N.; Pattanshetty, J. K.; Nayar, R. C., 1977: Pharmacognostical studies on the root of apama siliquosa aristolochiaceae

Nayar, R. C.; Pattan-Shetty, J. K.; Mary, Z.; Yoganarasimhan, S. N., 1978: Pharmacognostical studies on the root of decalepis hamiltonii and comparison with hemidesmus indicus

Satake M., 1983: Pharmacognostical studies on the umbelliferous crude drug qianghuo 1

Kohda, H.; Satake, M., 1982: Pharmacognostical studies on the umbelliferous crude drug qianhu 5. constituents of chinese qianhu

Namba, T.; Namba, K.; Kaneko, H.; Takahashi, S., 1976: Pharmacognostical studies on yen hu suo part 2 historical studies on yen hu suo in the chinese herbal and books of prescription part 2

Moustafa, S. M. I., 1986: Pharmacognostical study of fumaria densiflora dc part ii. leaf and flower

Mitra, R.; Srivastava, U. C., 1985: Pharmacognostical study of root bark of erythrina indica lam. paribhadra

Ghauri E.G., 1987: Pharmacognostical study on changeri

Nakamura M., 1986: Pharmacognostical study on the crude drug corni fructus shanzhuyu

Okuno I., 1984: Pharmacognostical study on the crude drug in jin go from korea

Tyler, V. E.; Brady, L. R.; Robbers, J. E., 1976: Pharmacognosy

Nayar, R. C.; Yoganarasimhan, S. N.; Subramanyam, K., 1976: Pharmacognosy of a local market sample of bharangi pygmaeopremna herbacea

Datta P.C., 1982: Pharmacognosy of allamanda cathartica bark drugs

Datta P.C., 1984: Pharmacognosy of alstonia scholaris bark drugs

Datta P.C., 1981: Pharmacognosy of aphanamixis polystachya stem bark

Srivastava, G. N.; Srivastava, A. K., 1988: Pharmacognosy of catharanthus roseus l. g. don sadabahar root and its adulterants

Datta P.C., 1984: Pharmacognosy of streblus bark drug

Khan A.M., 1982: Pharmacognosy of the stems of portulaca quadrifida and portulaca oleracea

Imo V., 1985: Pharmacognosy yesterday and today

Section 7, Chapter 6096, Accession 006095063

Johno, I.; Hasegawa, M.; Nakamura, T. A.; Ohshima, T.; Kitazawa, S.; Goto, M., 1986: Pharmacokinetic analyses and drug plasma level simulation by using a personal computer with unequal doses and dosing intervals

Aslam M., 1984: Pharmacokinetic analysis and calculations using a program for the minicomputer sharp pc 1500

Scharff M.D., 1987: Pharmacokinetic analysis of biosynthetically radiolabeled mouse monoclonal antibodies in normal rhesus monkey

Samejima M., 1987: Pharmacokinetic analysis of concentration data of drugs with irregular absorption profiles using multi fraction absorption models

Section 7, Chapter 6096, Accession 006095069

Section 7, Chapter 6096, Accession 006095070

Hayama T., 1984: Pharmacokinetic analysis of plasma concentration and urinary excretion of sulfamonomethoxine and its metabolite in goettingen minipigs

Section 7, Chapter 6096, Accession 006095072

Jamali F., 1988: Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs

Section 7, Chapter 6096, Accession 006095074

Gira G., 1986: Pharmacokinetic analysis of two differently constructed dose schedules for antiviral in vivo screening procedures

Michelson A.M., 1984: Pharmacokinetic and anti inflammatory properties in the rat of superoxide dismutases copper superoxide dismutase and manganese superoxide dismutase from various species

Ohnuma T., 1985: Pharmacokinetic and biochemical studies on acivicin in phase i clinical trials

Section 7, Chapter 6096, Accession 006095079

Section 7, Chapter 6096, Accession 006095080

Dominguez Gil A., 1987: Pharmacokinetic and clinical evaluation of ketamine administered by iv and epidural routes

Section 7, Chapter 6096, Accession 006095082

Takahashi A., 1985: Pharmacokinetic and clinical evaluations of micronomicin by intravenous drip infusion

Section 7, Chapter 6096, Accession 006095084

Section 7, Chapter 6096, Accession 006095085

Miyao M., 1987: Pharmacokinetic and clinical experience with flomoxef in bacterial infection of children

Section 7, Chapter 6096, Accession 006095087

Section 7, Chapter 6096, Accession 006095088

Section 7, Chapter 6096, Accession 006095089

Section 7, Chapter 6096, Accession 006095090

Section 7, Chapter 6096, Accession 006095091

Section 7, Chapter 6096, Accession 006095092

Section 7, Chapter 6096, Accession 006095093

Inokuma K., 1987: Pharmacokinetic and clinical studies of cefuzonam in pediatrics

Nishiya M., 1988: Pharmacokinetic and clinical studies of cefuzonam in the field of obstetrics and gynecology

Et Al, 1987: Pharmacokinetic and clinical studies of cefuzonam in the pediatric field

Section 7, Chapter 6096, Accession 006095097

Section 7, Chapter 6096, Accession 006095098

Section 7, Chapter 6096, Accession 006095099

Suzuki S., 1987: Pharmacokinetic and clinical studies of the effectiveness of cefuzonam on obstetric and gynecologic infections

Section 7, Chapter 6096, Accession 006095101

Section 7, Chapter 6096, Accession 006095102

Section 7, Chapter 6096, Accession 006095103

Section 7, Chapter 6096, Accession 006095104

Section 7, Chapter 6096, Accession 006095105

Watanabe H., 1987: Pharmacokinetic and clinical studies on cefuzonam in obstetrics and gynecology

Et Al, 1986: Pharmacokinetic and clinical studies on cefuzonam in the pediatric field

Kojima M., 1987: Pharmacokinetic and clinical studies on flomoxef in the pediatric field

Section 7, Chapter 6096, Accession 006095110

Section 7, Chapter 6096, Accession 006095111

Section 7, Chapter 6096, Accession 006095112

Baillie T.A., 1987: Pharmacokinetic and deuterium isotope effect studies on the metabolism of formaldehyde and formate to carbon dioxide in rats in vivo

Section 7, Chapter 6096, Accession 006095114

Section 7, Chapter 6096, Accession 006095115

Section 7, Chapter 6096, Accession 006095117

Schauder P., 1985: Pharmacokinetic and metabolic interrelationships among branched chain keto and amino acids in humans

Szeleczky, G.; Vereczkey, L., 1986: Pharmacokinetic and metabolic studies of vinpocetine on dogs i. pharmacokinetics

Szeleczky, G.; Vereczkey, L., 1986: Pharmacokinetic and metabolic studies of vinpocetine on dogs ii. metabolism

Delhon A., 1986: Pharmacokinetic and metabolic study of itanoxone in the crab pachygrapsus marmoratus decapoda brachyura comparative study with clofibric acid

Montgomery J.A., 1985: Pharmacokinetic and metabolism studies of two novel 1 deaza 7 8 dihydropteridines in mice

Coutts R.T., 1987: Pharmacokinetic and neurochemical studies on n propargyl 2 phenylethylamine a prodrug of 2 phenylethylamine

Section 7, Chapter 6096, Accession 006095124

Section 7, Chapter 6096, Accession 006095125

Bieck P.R., 1987: Pharmacokinetic and pharmacodynamic effects of the novel benzodiazepine antagonist 2 phenylpyrazolo 4 3 c quinolin 3 5h one in humans

Section 7, Chapter 6096, Accession 006095127

Section 7, Chapter 6096, Accession 006095128

Section 7, Chapter 6096, Accession 006095129

Section 7, Chapter 6096, Accession 006095130

Diczfalusy E., 1985: Pharmacokinetic and pharmacodynamic investigations with monthly injectable contraceptive preparations

Colburn W.A., 1986: Pharmacokinetic and pharmacodynamic modeling of cibenzoline plasma concentrations and antiarrhythmic effect

Section 7, Chapter 6096, Accession 006095133

Section 7, Chapter 6096, Accession 006095134

Section 7, Chapter 6096, Accession 006095135

Section 7, Chapter 6096, Accession 006095136

Section 7, Chapter 6096, Accession 006095137

Cepko H., 1986: Pharmacokinetic and pharmacodynamic studies in elderlies with a potential antihypoxidotic nootropic drug tenilsetam utilizing pharmacoelectroencephalography and psychometry

Section 7, Chapter 6096, Accession 006095139

Tazaki T., 1988: Pharmacokinetic and pharmacodynamic studies of butoctamide hydrogen succinate bahs

Section 7, Chapter 6096, Accession 006095141

Section 7, Chapter 6096, Accession 006095142

Section 7, Chapter 6096, Accession 006095143

Section 7, Chapter 6096, Accession 006095144

Section 7, Chapter 6096, Accession 006095145

Section 7, Chapter 6096, Accession 006095146

Section 7, Chapter 6096, Accession 006095147

Section 7, Chapter 6096, Accession 006095148

Naito S I., 1985: Pharmacokinetic and pharmacological studies on cetraxate an antiulcer agent

Section 7, Chapter 6096, Accession 006095150

Section 7, Chapter 6096, Accession 006095151

Section 7, Chapter 6096, Accession 006095152

Kim H K.C., 1985: Pharmacokinetic and therapeutic trial of sultamicillin in acute sinusitis

Forastiere, A. A.; Belliveau, J. F.; Goren, M. P.; Vogel, W. C.; Posner, M. R.; O'leary, G. P-Jr, 1988: Pharmacokinetic and toxicity evaluation of five day continuous infusion vs. intermittent bolus cis diamminedichloroplatinum ii in head and neck cancer patients

Heykants J., 1986: Pharmacokinetic approach to equilibrium between ketanserin and ketanserinol

Sakurai Y., 1988: Pharmacokinetic approach to rational therapeutic doses for human tumor bearing nude mice

Silber B.M., 1988: Pharmacokinetic approach to the rational design of controlled or sustained release formulations

Section 7, Chapter 6096, Accession 006095158

Landahl H.D., 1985: Pharmacokinetic approaches to drug distribution in the cerebrospinal fluid based on ventricular administration in beagle dogs

Section 7, Chapter 6096, Accession 006095160

Section 7, Chapter 6096, Accession 006095161

Section 7, Chapter 6096, Accession 006095162

Esteller A., 1987: Pharmacokinetic aspects of sulfobromophthalein transport after diethyl maleate pretreatment in rats

Magyar K., 1987: Pharmacokinetic aspects of the mode of action of egyt 475 a new antidepressant agent

Kadomoto N., 1987: Pharmacokinetic bacteriological and clinical studies of czon in the field of obstetrics and gynecology

Hayashi M., 1987: Pharmacokinetic bacteriological and clinical studies on cefuzonam in the field of obstetrics and gynecology

Section 7, Chapter 6096, Accession 006095167

Fourtillan J.B., 1988: Pharmacokinetic basis of bioavailability determinations

Pisanti N., 1984: Pharmacokinetic basis of monitoring of antiepileptic drugs

Young J.F., 1984: Pharmacokinetic basis of pharmacodynamic predictions

Section 7, Chapter 6096, Accession 006095171

Ravis W.R., 1985: Pharmacokinetic calculator program for generation of initial parameter estimates from a 3 compartment infusion model

Earon Y., 1987: Pharmacokinetic changes of several antibiotics of chickens during induced fatty liver

Section 7, Chapter 6096, Accession 006095174

Section 7, Chapter 6096, Accession 006095175

Section 7, Chapter 6096, Accession 006095176

Section 7, Chapter 6096, Accession 006095177

Section 7, Chapter 6096, Accession 006095178

Section 7, Chapter 6096, Accession 006095179

Section 7, Chapter 6096, Accession 006095180

Section 7, Chapter 6096, Accession 006095181

Section 7, Chapter 6096, Accession 006095182

Section 7, Chapter 6096, Accession 006095183

Section 7, Chapter 6096, Accession 006095184

Karpinski K., 1988: Pharmacokinetic disposition in sheep of various vitamin e preparations given orally or intravenously

Section 7, Chapter 6096, Accession 006095186

Slizeski M.L., 1986: Pharmacokinetic disposition of dmso administered intravenously to horses

Section 7, Chapter 6096, Accession 006095188

Mahoney C.J., 1988: Pharmacokinetic disposition of the novel atypical anxiolytic cgs 9896 in the cynomolgus monkey

Section 7, Chapter 6096, Accession 006095190

Section 7, Chapter 6096, Accession 006095191

Section 7, Chapter 6096, Accession 006095192

Distler A., 1984: Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease

Section 7, Chapter 6096, Accession 006095194

Solberg R., 1986: Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseases

Section 7, Chapter 6096, Accession 006095196

Section 7, Chapter 6096, Accession 006095197

Section 7, Chapter 6096, Accession 006095198

Section 7, Chapter 6096, Accession 006095199

Section 7, Chapter 6096, Accession 006095200

Section 7, Chapter 6096, Accession 006095201

Section 7, Chapter 6096, Accession 006095202

Section 7, Chapter 6096, Accession 006095203

Section 7, Chapter 6096, Accession 006095204

Tarbit M.H., 1985: Pharmacokinetic evaluation of uk 49858 a metabolically stable triazole antifungal drug in animals and humans

Section 7, Chapter 6096, Accession 006095206

Prelusky, D. B.; Hartin, K. E.; Trenholm, H. L.; Miller, J. D., 1988: Pharmacokinetic fate of carbon 14 labeled deoxynivalenol in swine

Section 7, Chapter 6096, Accession 006095208

Section 7, Chapter 6096, Accession 006095209

Section 7, Chapter 6096, Accession 006095210

Section 7, Chapter 6096, Accession 006095211

Larsen N E., 1985: Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment

Temesy Armos P.N., 1987: Pharmacokinetic implications of lorcainide therapy in patients with normal and depressed cardiac function

Section 7, Chapter 6096, Accession 006095214

Section 7, Chapter 6096, Accession 006095215

Section 7, Chapter 6096, Accession 006095216

Section 7, Chapter 6096, Accession 006095217

Section 7, Chapter 6096, Accession 006095218

Section 7, Chapter 6096, Accession 006095219

Section 7, Chapter 6096, Accession 006095220

Section 7, Chapter 6096, Accession 006095221

Section 7, Chapter 6096, Accession 006095222

Section 7, Chapter 6096, Accession 006095223

Pisanti N., 1988: Pharmacokinetic investigations on some antiepileptic drugs

Section 7, Chapter 6096, Accession 006095225

Lashev L., 1986: Pharmacokinetic investigations with birds

Dunne A., 1985: Pharmacokinetic lag time estimation

Wijnand H.P., 1988: Pharmacokinetic model equations for the one and two compartment models with first order processes in which the absorption and exponential elimination or distribution rate constants are equal

Hayton W.L., 1984: Pharmacokinetic model for the uptake and disposition of di 2 ethylhexyl phthalate in sheepshead minnow cyprinodon variegatus

Robbins D.C., 1988: Pharmacokinetic model of circulating covalent aggregates of insulin

Tojo K., 1988: Pharmacokinetic model of transcorneal drug delivery

Colburn W.A., 1985: Pharmacokinetic model to describe the disposition of lead in the rat

Section 7, Chapter 6096, Accession 006095233

Walshe J.J., 1986: Pharmacokinetic modeling of bidirectional transfer during peritoneal dialysis

Section 7, Chapter 6096, Accession 006095235

Francovitch R.J., 1987: Pharmacokinetic modeling of the lung burden from repeated inhalation of nickel aerosols

Luukkainen T., 1984: Pharmacokinetic observation on st 1435 administered subcutaneously and intravaginally

Section 7, Chapter 6096, Accession 006095238

Section 7, Chapter 6096, Accession 006095239

Beal S.L., 1985: Pharmacokinetic parameter estimates from several least squares procedures superiority of extended least squares

Section 7, Chapter 6096, Accession 006095241

Section 7, Chapter 6096, Accession 006095242

Garcia De Jalon P.D., 1986: Pharmacokinetic parameters of iodine 125 iodopropylidene glycerol in healthy volunteers

Section 7, Chapter 6096, Accession 006095244

Stein G., 1988: Pharmacokinetic pattern and renal effects of aluminum in rats with impaired kidney or liver function

Section 7, Chapter 6096, Accession 006095246

Liu X D., 1987: Pharmacokinetic perfusion model of presystemic metabolism with renal clearance

Section 7, Chapter 6096, Accession 006095248

Section 7, Chapter 6096, Accession 006095249

Section 7, Chapter 6096, Accession 006095250

Section 7, Chapter 6096, Accession 006095251

Van Boxtel C.J., 1988: Pharmacokinetic pharmacodynamic modelling of oxyprenolol in man using continuous non invasive blood pressure monitoring

Section 7, Chapter 6096, Accession 006095253

Jaeger H., 1984: Pharmacokinetic pilot study with imidazole 2 hydroxybenzoate using new analytical methods

Section 7, Chapter 6096, Accession 006095255

Nikolaev V.P., 1987: Pharmacokinetic principles of drugless prevention of drug hepatitides in patients with pulmonary tuberculosis

Section 7, Chapter 6096, Accession 006095257

Section 7, Chapter 6096, Accession 006095258

Section 7, Chapter 6096, Accession 006095259

Section 7, Chapter 6096, Accession 006095260

Section 7, Chapter 6096, Accession 006095261

Section 7, Chapter 6096, Accession 006095262

Hitzenberger G., 1986: Pharmacokinetic profile of imidazole 2 hydroxybenzoate a novel nonsteroidal antiinflammatory agent

Section 7, Chapter 6096, Accession 006095264

Philipp P., 1986: Pharmacokinetic profile of metaclazepam talis a new 1 4 benzodiazepine influence of different dosage regimens on the pharmacokinetic profile of metaclazepam and its main metabolite under steady state conditions

Ishizaki T., 1988: Pharmacokinetic profile of opc 8212 in humans a new nonglycosidic inotropic agent

Yonemitsu K., 1986: Pharmacokinetic profile of paraquat following intravenous administration to the rabbit

Abou Donia M.B., 1988: Pharmacokinetic profile of racemic gossypol in male sprague dawley rats following single intravenous and oral and subchronic oral administration

Section 7, Chapter 6096, Accession 006095269

Section 7, Chapter 6096, Accession 006095270

Section 7, Chapter 6096, Accession 006095271

Fujishima M., 1986: Pharmacokinetic properties of a new angiotensin i converting enzyme inhibitor alacepril in normal office workers

Section 7, Chapter 6096, Accession 006095273

Kobayashi S., 1988: Pharmacokinetic properties of ketanserin in patients with chronic renal failure after single dose oral administration

Section 7, Chapter 6096, Accession 006095275

Section 7, Chapter 6096, Accession 006095276

Chrousos G.P., 1987: Pharmacokinetic properties of the antiglucocorticoid and antiprogesterone steroid ru 486 in man

Section 7, Chapter 6096, Accession 006095278

Section 7, Chapter 6096, Accession 006095279

Salva P., 1986: Pharmacokinetic simulation with computers teaching application

Piotrovskii V.K., 1987: Pharmacokinetic stochastic model with weibull distributed residence times of drug molecules in the body

Wetzelsberger N., 1985: Pharmacokinetic studies in alizarin in man

Miyahara T., 1986: Pharmacokinetic studies of a new oral cephem t 2588 pharmacokinetics in gastrectomized volunteers and renal excretion system in healthy volunteers

Inoue A., 1986: Pharmacokinetic studies of astromicin using a constant rate continuous intravenous infusion method

Section 7, Chapter 6096, Accession 006095285

Vereczkey L., 1987: Pharmacokinetic studies of carbon 14 flumecinol in humans

Sugiyama Y., 1984: Pharmacokinetic studies of cefbuperazone in the field of gynecology

Section 7, Chapter 6096, Accession 006095288

Section 7, Chapter 6096, Accession 006095289

Shevcheno V.E., 1984: Pharmacokinetic studies of cyclophosphane in hemosorption in lung cancer patients

Section 7, Chapter 6096, Accession 006095291

Section 7, Chapter 6096, Accession 006095292

Reichlin S., 1987: Pharmacokinetic studies of highly purified human prolactin in normal human subjects

Matsuyama K., 1987: Pharmacokinetic studies of intermediate to high dose 1 beta d arabinofuranosylcytosine in children with acute leukemia and lymphoma

Section 7, Chapter 6096, Accession 006095295

Section 7, Chapter 6096, Accession 006095296

Section 7, Chapter 6096, Accession 006095297

Section 7, Chapter 6096, Accession 006095298

Section 7, Chapter 6096, Accession 006095299

Hayashida, K.; Akaike, Y.; Nakamura, S.; Miura, Y.; Arai, Y.; Ono, Y.; Takeyama, S., 1987: Pharmacokinetic studies on 1 2 chloroethyl 3 isobutyl 3 beta maltosyl 1 nitrosourea ta 077 i. blood and tissue concentrations of a new nitrosourea antitumor agent ta 077 and its metabolite ta g after intravenous injection of ta 077 in various experimental animals

Hayashida, K.; Oda, K.; Akaike, Y.; Arai, Y.; Takeyama, S., 1987: Pharmacokinetic studies on 1 2 chloroethyl 3 isobutyl 3 beta maltosyl 1 nitrosourea ta 077 ii. hydrolysis by tissue homogenates and drug uptake by tumor cells in vitro

Hayashida, K.; Miura, Y.; Arai, Y.; Takeyama, S.; Wakui, A.; Yokoyama, M.; Kanamaru, R.; Majima, H.; Taguchi, T.; Et-Al, 1987: Pharmacokinetic studies on 1 2 chloroethyl 3 isobutyl 3 beta maltosyl 1 nitrosourea ta 077 iii. pharmacokinetics of a new nitrosourea antitumor agent ta 077 in humans a phase i study

Section 7, Chapter 6096, Accession 006095304

Acocella, G.; Conti, R.; Luisetti, M.; Pozzi, E.; Grassi, C., 1985: Pharmacokinetic studies on antituberculosis regimens in humans 1. absorption and metabolism of the compounds used in the initial intensive phase of the short course regimens single administration study

Deguchi T., 1986: Pharmacokinetic studies on astromicin in dogs intramuscular intravenous or drip intravenous administration

Section 7, Chapter 6096, Accession 006095307

Section 7, Chapter 6096, Accession 006095308

Section 7, Chapter 6096, Accession 006095309

Del Mastro S., 1986: Pharmacokinetic studies on ceftezole

Section 7, Chapter 6096, Accession 006095311

Section 7, Chapter 6096, Accession 006095312

Section 7, Chapter 6096, Accession 006095314

Yi M G., 1985: Pharmacokinetic studies on tritiated aclacinomycin b in mice

Section 7, Chapter 6096, Accession 006095316

Section 7, Chapter 6096, Accession 006095317

Section 7, Chapter 6096, Accession 006095318

Jori G., 1987: Pharmacokinetic studies with zinc ii phthalocyanine tumor bearing mice

Section 7, Chapter 6096, Accession 006095320

Section 7, Chapter 6096, Accession 006095321

De Angelis M., 1988: Pharmacokinetic study in man with the non steroidal antiinflammatory drug flunoxaprofen serum concentration time profile after oral or topical preparations

Section 7, Chapter 6096, Accession 006095323

Schmit J M., 1987: Pharmacokinetic study of 2 dehydroemetine in the hemodialyzed chronic renal insufficiency patient

Hanano M., 1987: Pharmacokinetic study of 4 methylumbelliferone in mice

Hanano M., 1986: Pharmacokinetic study of 4 methylumbelliferone in rats influence of dose on its first pass hepatic elimination

Section 7, Chapter 6096, Accession 006095327

Bannai, H.; Tatsumi, M.; Kohase, M.; Onishi, E.; Tamazaki, S., 1985: Pharmacokinetic study of a human recombinant interferon in cynomolgus monkeys by 2' 5' oligoadenylate synthetase assay

Louw E.A., 1985: Pharmacokinetic study of a pediatric formulation of amoxycillin and clavulanic acid in children

Fomina I.P., 1987: Pharmacokinetic study of aclarubicin blood pharmacokinetics of the drug and its biologically active metabolites in rats

Terent'eva T.G., 1987: Pharmacokinetic study of aclarubicin distribution of the drug and its biologically active metabolites in the tissues of rats

Martin P., 1982: Pharmacokinetic study of adriamycin in dogs and rabbits in absence of carrier

Section 7, Chapter 6096, Accession 006095333

Section 7, Chapter 6096, Accession 006095334

Section 7, Chapter 6096, Accession 006095335

Okada A., 1985: Pharmacokinetic study of cefsulodin in children

Section 7, Chapter 6096, Accession 006095337

Section 7, Chapter 6096, Accession 006095338

Guo J., 1988: Pharmacokinetic study of chromium preparation in rabbits by compartment and non compartment analysis

Thuillier A., 1987: Pharmacokinetic study of cicletanine hydrochloride in renal failure

Morishita N., 1986: Pharmacokinetic study of deuterium labeled coenzyme q 10 in man

Section 7, Chapter 6096, Accession 006095342

Section 7, Chapter 6096, Accession 006095343

Section 7, Chapter 6096, Accession 006095344

Gutierrez J.A., 1987: Pharmacokinetic study of guanyl cysteine

Rouleau P., 1986: Pharmacokinetic study of ioxaglate a low osmolality contrast medium in patients with renal failure

Tahvanainen P., 1985: Pharmacokinetic study of iv infusions of adriamycin

Section 7, Chapter 6096, Accession 006095348

Section 7, Chapter 6096, Accession 006095349

Kulakov V.N., 1986: Pharmacokinetic study of medicinal polymers radioisotope methods of pharmacokinetic studies

Section 7, Chapter 6096, Accession 006095351

Section 7, Chapter 6096, Accession 006095352

Quesada J.R., 1984: Pharmacokinetic study of partially pure gamma interferon in cancer patients

Obata T., 1987: Pharmacokinetic study of peplomycin given by continuous infusion from the vagina or cervix in squamous cell carcinoma of the uterine cervix

Burzynski S.R., 1987: Pharmacokinetic study of radioactive antineoplaston a10 following oral administration in rats

Koprowski H., 1985: Pharmacokinetic study of radiolabeled anti colorectal carcinoma monoclonal antibodies in tumor bearing nude mice

Yoo M Y., 1987: Pharmacokinetic study of recombinant human interferon alpha a in rats

Section 7, Chapter 6096, Accession 006095358

Sumano Lopez H., 1988: Pharmacokinetic study of sodium sulfadimethylpyrimidine in goats to evaluate its action on mastitis

Takashi A., 1984: Pharmacokinetic study of sultopride

Section 7, Chapter 6096, Accession 006095361

Gutierrez J.A., 1987: Pharmacokinetic study of trihydrated pipemidic acid following intravenous infusion

Berger J.A., 1984: Pharmacokinetic study of tritium labeled paf acether platelet activating factor 2 comparison with tritium labeled lyso paf acether after intravenous administration in the rabbit and protein binding

Cadorniga L., 1984: Pharmacokinetic study of vincamine teprosilate

Rossi, C.; Zucchetti, M.; Sessa, C.; Urso, R.; Mangioni, C.; D'incalci, M., 1984: Pharmacokinetic study of vm 26 4' demethylepipodephyllotoxin 9 4 6 o 2 thenylidene beta d glucopyranoside given as a prolonged intravenous infusion to ovarian cancer patients

Section 7, Chapter 6096, Accession 006095367

Section 7, Chapter 6096, Accession 006095368

Section 7, Chapter 6096, Accession 006095369

Section 7, Chapter 6096, Accession 006095370

Section 7, Chapter 6096, Accession 006095371

Section 7, Chapter 6096, Accession 006095372

Siegel, R. A., 1986: Pharmacokinetic transfer functions and generalized clearances

Taneda Y., 1987: Pharmacokinetical bacteriological and clinical studies of flomoxef in the pediatric field

Section 7, Chapter 6096, Accession 006095375

Section 7, Chapter 6096, Accession 006095376

Section 7, Chapter 6096, Accession 006095377

Shindo Y., 1987: Pharmacokinetics and acute effect on the renin angiotensin system of delapril in patients with chronic renal failure

Section 7, Chapter 6096, Accession 006095379

Aitkenhead A.R., 1984: Pharmacokinetics and analgesic effect of slow release oral morphine sulfate in volunteers

Romdane M.N., 1988: Pharmacokinetics and anti dicrocoelium effect of thiophanate and its major metabolite in ruminants

Loadman P.M., 1986: Pharmacokinetics and anti tumor activity of lm 985 in mice bearing transplantable adenocarcinomas of the colon

Section 7, Chapter 6096, Accession 006095383

Vogel G., 1984: Pharmacokinetics and anticoagulant effect of hirudin in man

Min B.H., 1987: Pharmacokinetics and antisecretory activity of trimoprostil in heidenhain pouch dogs

Section 7, Chapter 6096, Accession 006095386

Section 7, Chapter 6096, Accession 006095387

Petruska M., 1985: Pharmacokinetics and bactericidal activity of sultamicillin in infants and children

Section 7, Chapter 6096, Accession 006095389

Section 7, Chapter 6096, Accession 006095390

Section 7, Chapter 6096, Accession 006095391

Yates M.S., 1987: Pharmacokinetics and biliary excretion of rose bengal in rats with acute and chronic renal failure

Section 7, Chapter 6096, Accession 006095393

Section 7, Chapter 6096, Accession 006095394

Section 7, Chapter 6096, Accession 006095395

Greenblatt D.J., 1985: Pharmacokinetics and bioavailability of ciramadol a new analgesic

Section 7, Chapter 6096, Accession 006095400

Patrick J.E., 1988: Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers

Section 7, Chapter 6096, Accession 006095402

Section 7, Chapter 6096, Accession 006095403

Section 7, Chapter 6096, Accession 006095404

Weintraub H.S., 1988: Pharmacokinetics and bioavailability of etintidine in beagle dogs effects of routes of administration doses dosage forms and chronic dosing

Section 7, Chapter 6096, Accession 006095406

Section 7, Chapter 6096, Accession 006095407

Section 7, Chapter 6096, Accession 006095408

Section 7, Chapter 6096, Accession 006095409

Hickey M.P., 1985: Pharmacokinetics and bioavailability of pinacidil capsules in human volunteers

Section 7, Chapter 6096, Accession 006095411

Section 7, Chapter 6096, Accession 006095412

Section 7, Chapter 6096, Accession 006095413

Section 7, Chapter 6096, Accession 006095414

Piulats J., 1986: Pharmacokinetics and bioavailability of reproterol after intratracheal administration in the rat

Section 7, Chapter 6096, Accession 006095416

Section 7, Chapter 6096, Accession 006095418

Courtois P., 1985: Pharmacokinetics and bioavailability of viqualine a new antidepressant

Malik J.K., 1986: Pharmacokinetics and biochemical effects of diacetyl monoxime in bubalus bubalis

Section 7, Chapter 6096, Accession 006095421

Ifflaender U., 1987: Pharmacokinetics and bioequivalence of two peroral beclobrate preparations

Heinke P., 1987: Pharmacokinetics and biological activity of the new intermediate acting insulin l snc

Section 7, Chapter 6096, Accession 006095424

Section 7, Chapter 6096, Accession 006095425

Section 7, Chapter 6096, Accession 006095427

Antony A., 1988: Pharmacokinetics and chemotherapeutic efficacy of adriamycin encapsulated in immunoliposomes against avian myeloblastosis virus infection

Section 7, Chapter 6096, Accession 006095429

Et Al, 1987: Pharmacokinetics and clinical effects of aspoxicillin in pediatric patients

Section 7, Chapter 6096, Accession 006095431

Section 7, Chapter 6096, Accession 006095432

Section 7, Chapter 6096, Accession 006095433

Section 7, Chapter 6096, Accession 006095434

Section 7, Chapter 6096, Accession 006095435

Section 7, Chapter 6096, Accession 006095436

Section 7, Chapter 6096, Accession 006095437

Section 7, Chapter 6096, Accession 006095438

Section 7, Chapter 6096, Accession 006095439

Section 7, Chapter 6096, Accession 006095440

Et Al, 1987: Pharmacokinetics and clinical studies of flomoxef in the pediatric field

Section 7, Chapter 6096, Accession 006095442

Fukunaga K., 1985: Pharmacokinetics and clinical studies on cefminox in obstetrics and gynecology

Kunii K., 1985: Pharmacokinetics and clinical studies on cefpimizole in obstetrics and gynecology

Section 7, Chapter 6096, Accession 006095445

Proudfoot A.T., 1985: Pharmacokinetics and clinical toxicity of quinine overdosage lack of efficacy of techniques intended to enhance elimination

Section 7, Chapter 6096, Accession 006095447

Section 7, Chapter 6096, Accession 006095448

Section 7, Chapter 6096, Accession 006095449

Kaneko Y., 1987: Pharmacokinetics and depressor effect of delapril in patients with essential hypertension

Section 7, Chapter 6096, Accession 006095451

Section 7, Chapter 6096 , Accession 006095452

Section 7, Chapter 6096, Accession 006095453

Chaudhary A.K., 1985: Pharmacokinetics and disposition of chandonium iodide in monkey macaca mulatta

Chaudhary A.K., 1985: Pharmacokinetics and disposition of chandonium iodide in rat

Section 7, Chapter 6096, Accession 006095456

Srivastava A.K., 1987: Pharmacokinetics and dosage of sulfadimidine in cross bred calves

Aisner J., 1984: Pharmacokinetics and dosage reduction of cis diammine 1 1 cyclobutanedicarboxylatoplatinum in patients with impaired renal function

Section 7, Chapter 6096, Accession 006095460

Section 7, Chapter 6096, Accession 006095461

Paxton L.M., 1986: Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration

Section 7, Chapter 6096, Accession 006095463

Section 7, Chapter 6096, Accession 006095464

Strobel K., 1987: Pharmacokinetics and dose recommendations of carumonam in renal failure

Section 7, Chapter 6096, Accession 006095466

Section 7, Chapter 6096, Accession 006095467

Section 7, Chapter 6096, Accession 006095468

Section 7, Chapter 6096, Accession 006095469

Section 7, Chapter 6096, Accession 006095470

Section 7, Chapter 6096, Accession 006095471

Section 7, Chapter 6096, Accession 006095472

Section 7, Chapter 6096, Accession 006095473

Section 7, Chapter 6096, Accession 006095474

Section 7, Chapter 6096, Accession 006095475

Section 7, Chapter 6096, Accession 006095476

Dominguez Gil A., 1985: Pharmacokinetics and efficacy indices of dibekacin following its administration by different routes

Section 7, Chapter 6096, Accession 006095479

Roche H., 1986: Pharmacokinetics and efficacy of intravenous and intraperitoneal vm 26 chemotherapy in mice bearing krebs ii ascitic tumors

Section 7, Chapter 6096, Accession 006095481

Castagnoli N.Jr, 1987: Pharmacokinetics and excretion of unique beta adrenergic agonists

Section 7, Chapter 6096, Accession 006095483

Section 7, Chapter 6096, Accession 006095484

Section 7, Chapter 6096, Accession 006095485

Section 7, Chapter 6096, Accession 006095486

Section 7, Chapter 6096, Accession 006095487

Section 7, Chapter 6096, Accession 006095488

Section 7, Chapter 6096, Accession 006095489

Section 7, Chapter 6096, Accession 006095490

Carrasco S., 1985: Pharmacokinetics and initial distribution of a new neuroleptic agent picobenzide m 14012 4

Section 7, Chapter 6096, Accession 006095492

Section 7, Chapter 6096, Accession 006095493

Orrenius S., 1984: Pharmacokinetics and mechanism of action of detoxifying low molecular weight thiols

Srivastava R.C., 1987: Pharmacokinetics and metabolic disposition of nickel in poisoned rats effect of chelating drugs

Section 7, Chapter 6096, Accession 006095496

Fauran F., 1984: Pharmacokinetics and metabolic study of itanoxone in adult

Dain J.G., 1987: Pharmacokinetics and metabolism of alpha dimethylaminomethyl 2 3 ethyl 5 methyl 4 isoxazolyl 1h indole 3 methanol a hypoglycemic agent in man

Symchowicz S., 1987: Pharmacokinetics and metabolism of an intravenously administered penem sch 34343 in humans

Setnikar I., 1987: Pharmacokinetics and metabolism of carbon 14 proglumetacin after oral administration in the rat

Symchowicz S., 1986: Pharmacokinetics and metabolism of carbon 14 rosaramicin in dogs

Section 7, Chapter 6096, Accession 006095502

Eckhardt S., 1986: Pharmacokinetics and metabolism of dianhydrogalactitol in patients a comparison with the human disposition of dibromodulcitol

Section 7, Chapter 6096, Accession 006095504

Section 7, Chapter 6096, Accession 006095505

Section 7, Chapter 6096, Accession 006095506

Section 7, Chapter 6096, Accession 006095507

Abikhalil F., 1986: Pharmacokinetics and metabolism of hexamethylmelamine in mice after ip administration

Section 7, Chapter 6096, Accession 006095509

Section 7, Chapter 6096, Accession 006095510

Section 7, Chapter 6096, Accession 006095512

Chauvergne J., 1988: Pharmacokinetics and metabolism of pirarubicin in advanced cancer patients

Section 7, Chapter 6096, Accession 006095514

Symchowicz S., 1984: Pharmacokinetics and metabolism of rosaramicin in humans

Pacheco H., 1985: Pharmacokinetics and metabolism of s adenosyl l homocysteine in rats and dog

Section 7, Chapter 6096, Accession 006095517

Donath A., 1985: Pharmacokinetics and metabolism of the antiarrhythmic carocainide in man

Powis G., 1988: Pharmacokinetics and metabolism of the antitumor agent sulfamic acid 1 7 hepatanediyl ester sulfamic acid diester in the mouse and beagle dog

Section 7, Chapter 6096, Accession 006095520

Toja E., 1985: Pharmacokinetics and metabolism of tomoxiprole a new analgesic antiinflammatory agent in the rat

Section 7, Chapter 6096, Accession 006095522

Section 7, Chapter 6096, Accession 006095523

Section 7, Chapter 6096, Accession 006095524

Section 7, Chapter 6096, Accession 006095525

Section 7, Chapter 6096, Accession 006095526

Section 7, Chapter 6096, Accession 006095527

Section 7, Chapter 6096, Accession 006095528

Section 7, Chapter 6096, Accession 006095529

Section 7, Chapter 6096, Accession 006095530

Section 7, Chapter 6096, Accession 006095531

Section 7, Chapter 6096, Accession 006095532

Section 7, Chapter 6096, Accession 006095533

Ankier S.I., 1985: Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam a new benzodiazepine hypnotic

Krause, W.; Sauerbrey, N.; Graef, K. J., 1986: Pharmacokinetics and pharmacodynamics in man of the dopamine antagonist ergot derivative bromerguride

Section 7, Chapter 6096, Accession 006095536

Section 7, Chapter 6096, Accession 006095537

Section 7, Chapter 6096, Accession 006095538

Section 7, Chapter 6096, Accession 006095539

Section 7, Chapter 6096, Accession 006095540

Section 7, Chapter 6096, Accession 006095541

Woosley R.L., 1987: Pharmacokinetics and pharmacodynamics of antiarrhythmic agents in patients with congestive heart failure

Section 7, Chapter 6096, Accession 006095543

Section 7, Chapter 6096, Accession 006095544

Section 7, Chapter 6096, Accession 006095545

Section 7, Chapter 6096, Accession 006095546

Section 7, Chapter 6096 , Accession 006095547

Section 7, Chapter 6096, Accession 006095548

Section 7, Chapter 6096, Accession 006095549

Section 7, Chapter 6096, Accession 006095550

Section 7, Chapter 6096, Accession 006095551

Norlen L.J., 1985: Pharmacokinetics and pharmacodynamics of emepronium bromide cetiprin after intravenous administration in man

Section 7, Chapter 6096, Accession 006095553

Hahn N., 1987: Pharmacokinetics and pharmacodynamics of epinephrine administered endobronchially

Section 7, Chapter 6096, Accession 006095555

Matier W.L., 1987: Pharmacokinetics and pharmacodynamics of flestolol a new short acting beta adrenergic receptor antagonist

Section 7, Chapter 6096, Accession 006095557

Gyselby G., 1986: Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra articular administration

Section 7, Chapter 6096, Accession 006095559

Section 7, Chapter 6096, Accession 006095560

Fritz H., 1988: Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration

Wills R.J., 1985: Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteers

Section 7, Chapter 6096, Accession 006095563

Section 7, Chapter 6096, Accession 006095564

Section 7, Chapter 6096, Accession 006095565

Section 7, Chapter 6096, Accession 006095566

Section 7, Chapter 6096, Accession 006095567

Section 7, Chapter 6096, Accession 006095568

Section 7, Chapter 6096, Accession 006095569

Section 7, Chapter 6096, Accession 006095570

Section 7, Chapter 6096, Accession 006095571

Huang R H., 1988: Pharmacokinetics and pharmacodynamics of p aminopropiophenone in rabbits

Huang R H., 1988: Pharmacokinetics and pharmacodynamics of p hydroxylaminopropiophenone

Brunner H.R., 1986: Pharmacokinetics and pharmacodynamics of pentopril a new angiotensin converting enzyme inhibitor in humans

Section 7, Chapter 6096, Accession 006095575

Section 7, Chapter 6096, Accession 006095576

Section 7, Chapter 6096, Accession 006095577

Section 7, Chapter 6096, Accession 006095578

Section 7, Chapter 6096, Accession 006095579

Section 7, Chapter 6096, Accession 006095580

Section 7, Chapter 6096, Accession 006095581

Inturrisi C.E., 1985: Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat

Section 7, Chapter 6096, Accession 006095583

Section 7, Chapter 6096, Accession 006095584

Eyer P., 1986: Pharmacokinetics and pharmacodynamics of the oxime hi6 in dogs

Section 7, Chapter 6096, Accession 006095586

Section 7, Chapter 6096, Accession 006095587

Jonkman J.H.G., 1987: Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients

Section 7, Chapter 6096, Accession 006095589

Ramanathan K.B., 1988: Pharmacokinetics and pharmacodynamics of urapidil in severe hypertension

Section 7, Chapter 6096, Accession 006095591

Section 7, Chapter 6096, Accession 006095592

Section 7, Chapter 6096, Accession 006095593

Section 7, Chapter 6096, Accession 006095594

Section 7, Chapter 6096, Accession 006095595

Lefebvre P.J., 1987: Pharmacokinetics and pharmacological properties of two galenical preparations of glibenclamide hb 419 and hb 420 in non insulin dependent type 2 diabetes

Section 7, Chapter 6096, Accession 006095597

Section 7, Chapter 6096, Accession 006095598

Ashley J.J., 1985: Pharmacokinetics and plasma concentration effect relationships of prenalterol in cardiac failure

Section 7, Chapter 6096, Accession 006095600

Section 7, Chapter 6096, Accession 006095601

Yagen B., 1988: Pharmacokinetics and protein binding of trichothecene mycotoxins t 2 toxin and ht 2 toxin in dogs

Section 7, Chapter 6096, Accession 006095603

Section 7, Chapter 6096, Accession 006095604

Section 7, Chapter 6096, Accession 006095606

Section 7, Chapter 6096, Accession 006095607

Simon M., 1987: Pharmacokinetics and renal elimination of desferrioxamine and ferrioxamine in healthy subjects and patients with hemochromatosis

Section 7, Chapter 6096, Accession 006095609

Section 7, Chapter 6096, Accession 006095610

Section 7, Chapter 6096, Accession 006095611

Section 7, Chapter 6096, Accession 006095612

Hasebe T., 1988: Pharmacokinetics and safety of levo carnitine infused iv in healthy subjects

Section 7, Chapter 6096, Accession 006095614

Section 7, Chapter 6096, Accession 006095615

Section 7, Chapter 6096, Accession 006095616

Section 7, Chapter 6096, Accession 006095617

Section 7, Chapter 6096, Accession 006095618

Section 7, Chapter 6096, Accession 006095619

Section 7, Chapter 6096, Accession 006095620

Mehta A.C., 1987: Pharmacokinetics and the analytical chemist

Serebryakova T.V., 1986: Pharmacokinetics and the clinical effect of bemitil following a single administration

Section 7, Chapter 6096, Accession 006095623

Section 7, Chapter 6096, Accession 006095624

Section 7, Chapter 6096, Accession 006095625

Section 7, Chapter 6096, Accession 006095626

Section 7, Chapter 6096, Accession 006095627

Section 7, Chapter 6096, Accession 006095628

Hortobagyi G.N., 1986: Pharmacokinetics and tissue disposition of the biological response modifier bay i 7433 copovithane in patients with cancer

Section 7, Chapter 6096, Accession 006095630

Section 7, Chapter 6096, Accession 006095631

Heykants J., 1988: Pharmacokinetics and tissue distribution of ketanserin in rat rabbit and dog

Section 7, Chapter 6096, Accession 006095633

Section 7, Chapter 6096, Accession 006095634

Section 7, Chapter 6096, Accession 006095635

Baughman R.A., 1988: Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor alpha in mice

Section 7, Chapter 6096, Accession 006095637

Yi M G., 1986: Pharmacokinetics and tissue distribution of tritiated ginsenoside r g 1

Wise R., 1985: Pharmacokinetics and tissue penetration of carumonam a new synthetic monobactam

Section 7, Chapter 6096, Accession 006095640

Griggs D.J., 1987: Pharmacokinetics and tissue penetration of ro 23 6240 a new trifluoroquinolone

Section 7, Chapter 6096, Accession 006095642

Section 7, Chapter 6096, Accession 006095644

Section 7, Chapter 6096, Accession 006095645

Prasad A.S., 1984: Pharmacokinetics and tolerance of intravenous and intramuscular recombinant alpha 2 interferon in patients with malignancies

Section 7, Chapter 6096, Accession 006095647

Section 7, Chapter 6096, Accession 006095648

Haughey D.B., 1987: Pharmacokinetics and toxicity of high dose human alpha 1 acid glycoprotein infusion in the rat

Pond S.M., 1988: Pharmacokinetics and toxicity of high doses of antibody fab fragments in rats

Section 7, Chapter 6096, Accession 006095651

Section 7, Chapter 6096, Accession 006095652

Section 7, Chapter 6096, Accession 006095653

Eyer P., 1985: Pharmacokinetics and toxicity of the oxime hgg 12 in dogs

Section 7, Chapter 6096, Accession 006095655

Et Al, 1988: Pharmacokinetics and urinary excretion of aspoxicillin after consecutive administration at a dose of 4 gram

Section 7, Chapter 6096, Accession 006095657

Schleusener H., 1987: Pharmacokinetics and urinary excretion of orally administered diiodotyrosine

Durand R.E., 1985: Pharmacokinetics binding and distribution of hoechst 33342 in spheroids and murine tumors

Section 7, Chapter 6096, Accession 006095660

Section 7, Chapter 6096, Accession 006095661

Section 7, Chapter 6096, Accession 006095662

Van Nueten J.M., 1988: Pharmacokinetics evaluation of the in vitro and in vivo pharmacological profile of the major metabolites of ketanserin in the rat

Arnaud M.J., 1985: Pharmacokinetics in animal chronic toxicological studies

Section 7, Chapter 6096, Accession 006095665

Section 7, Chapter 6096, Accession 006095666

Yata N., 1985: Pharmacokinetics in hepatic transport of amaranth in rats intoxicated with carbon tetrachloride and alpha naphthylisothiocyanate

Silvers A., 1986: Pharmacokinetics in low dose extrapolation using animal cancer data

Segre G., 1984: Pharmacokinetics in man of glysolamide a low dose oral antidiabetic drug

Section 7, Chapter 6096, Accession 006095670

Weiss M., 1985: Pharmacokinetics in target tissues

Zinelli L.C., 1984: Pharmacokinetics in the elderly

Section 7, Chapter 6096, Accession 006095673

Tozer T.N., 1988: Pharmacokinetics in the rat and the dog of a nonionic nitroxide contrast agent for magnetic resonance imaging

Section 7, Chapter 6096, Accession 006095675

Mico B.A., 1986: Pharmacokinetics metabolism and disposition of 6 chloro 2 3 4 5 tetrahydro 3 methyl 1h 3 benzazepine skf 86466 in rats and dogs

Section 7, Chapter 6096, Accession 006095677

Section 7, Chapter 6096, Accession 006095678

Baakman M., 1986: Pharmacokinetics metabolism and renal excretion of sulfadimidine and its n 4 acetyl and hydroxy metabolites in humans

Nouws J.F.M., 1986: Pharmacokinetics metabolism and renal excretion of sulfatroxazole and its 5 hydroxy and n 4 acetyl metabolites in man

Section 7, Chapter 6096, Accession 006095681

Morton D.J., 1984: Pharmacokinetics of 12 anticonvulsant drugs in the rat

Section 7, Chapter 6096, Accession 006095683

Srivastava A.K., 1986: Pharmacokinetics of 2 3 butanedione monoxime in bubalus bubalis after intravenous administration

Section 7, Chapter 6096, Accession 006095685

Section 7, Chapter 6096, Accession 006095686

Section 7, Chapter 6096, Accession 006095687

Neidlein, R.; Deigner, H. P., 1988: Pharmacokinetics of 4 oxa 5 exo n methylcarbamoyloxytricyclo 5.2.1.02 6e n d o dec 8 en 3one in the rat

Section 7, Chapter 6096, Accession 006095689

Section 7, Chapter 6096, Accession 006095690

Section 7, Chapter 6096, Accession 006095691

Section 7, Chapter 6096, Accession 006095692

D'incalci M., 1987: Pharmacokinetics of 7 con o methylnogarol in patients with solid tumors

Section 7, Chapter 6096, Accession 006095694

Bogaert M.G., 1988: Pharmacokinetics of 8 methoxypsoralen in the dog

Cavenaghi L., 1988: Pharmacokinetics of a 40926 in rats after single intravenous and subcutaneous doses

Section 7, Chapter 6096, Accession 006095697

Section 7, Chapter 6096, Accession 006095698

Section 7, Chapter 6096, Accession 006095699

Section 7, Chapter 6096, Accession 006095700

Section 7, Chapter 6096, Accession 006095701

Fujishima M., 1985: Pharmacokinetics of a new angiotensin i converting enzyme inhibitor alacepril after oral dosing in fasting or fed states

Omae T., 1988: Pharmacokinetics of a new angiotensin i converting enzyme inhibitor delapril in patients with deteriorated kidney function and in normal control subjects

Rossi Ferrini P., 1986: Pharmacokinetics of a new heat treated concentrate of factor viii estimated by model independent methods

Caldwell W., 1988: Pharmacokinetics of a new inotropic catecholamine in dog plasma using solid phase extraction technology

Section 7, Chapter 6096, Accession 006095706

Irikura T., 1986: Pharmacokinetics of a new quinolone am 833 in mice rats rabbits dogs and monkeys

Sakhibov A.D., 1987: Pharmacokinetics of a polymer metal complex ii

Mico B.A., 1988: Pharmacokinetics of a series of 6 chloro 2 3 4 5 tetrahydro 3 substituted 1h 3 benzazepines in rats determination of quantitative structure pharmacokinetic relationships

Section 7, Chapter 6096, Accession 006095710

Section 7, Chapter 6096, Accession 006095711

Shapiro A.B., 1988: Pharmacokinetics of a spin labeled rubomycin analog

Section 7, Chapter 6096, Accession 006095713

Section 7, Chapter 6096, Accession 006095714

Section 7, Chapter 6096, Accession 006095715

Section 7, Chapter 6096, Accession 006095716

Section 7, Chapter 6096, Accession 006095717

Section 7, Chapter 6096, Accession 006095718

Section 7, Chapter 6096, Accession 006095719

Chen R X., 1987: Pharmacokinetics of aclacinomycin a in normal rats and mice bearing sarcoma 180 s 180

Uchino H., 1986: Pharmacokinetics of aclarubicin and its metabolites in humans and their disposition in blood cells

Ludwig B., 1987: Pharmacokinetics of aditoprim a new long acting dihydrofolate reductase inhibitor in heifers

Section 7, Chapter 6096, Accession 006095723

Section 7, Chapter 6096, Accession 006095725

Section 7, Chapter 6096, Accession 006095726

Section 7, Chapter 6096, Accession 006095727

Section 7, Chapter 6096, Accession 006095728

Doucet D., 1986: Pharmacokinetics of alminoprofen in healthy subjects influence of the time of administration

Grillo Lopez A.J., 1987: Pharmacokinetics of ametantrone acetate nsc 287513

Section 7, Chapter 6096, Accession 006095731

Section 7, Chapter 6096, Accession 006095732

Section 7, Chapter 6096, Accession 006095733

Section 7, Chapter 6096, Accession 006095734

Section 7, Chapter 6096, Accession 006095735

Section 7, Chapter 6096, Accession 006095736

Section 7, Chapter 6096, Accession 006095737

Section 7, Chapter 6096, Accession 006095738

Barrientos A., 1986: Pharmacokinetics of aminoglycoside antibiotics in patients with renal failure undergoing hemofiltration 1

Barrientos A., 1986: Pharmacokinetics of aminoglycoside antibiotics in patients with renal failure undergoing hemofiltration ii

Section 7, Chapter 6096, Accession 006095741

Section 7, Chapter 6096, Accession 006095742

Section 7, Chapter 6096, Accession 006095743

Kawamura S., 1984: Pharmacokinetics of amosulalol an alpha beta adrenoceptor blocker in rats dogs and monkeys

Section 7, Chapter 6096, Accession 006095745

Section 7, Chapter 6096, Accession 006095746

Section 7, Chapter 6096, Accession 006095747

Section 7, Chapter 6096, Accession 006095748

Section 7, Chapter 6096, Accession 006095749

Section 7, Chapter 6096, Accession 006095750

Section 7, Chapter 6096, Accession 006095751

Jin B Q., 1986: Pharmacokinetics of amygdalin in rabbits

Hayashi T., 1988: Pharmacokinetics of an active cadralazine metabolite in plasma and blood vessels of spontaneously hypertensive rats

Petitjean O., 1985: Pharmacokinetics of an anticholinesterasic agent eserine n oxide in humans after administration of two galenic forms

Section 7, Chapter 6096, Accession 006095755

Section 7, Chapter 6096, Accession 006095756

Bertagna C., 1988: Pharmacokinetics of anandron in patients with advanced carcinoma of the prostate

Section 7, Chapter 6096, Accession 006095758

Section 7, Chapter 6096, Accession 006095759

Section 7, Chapter 6096, Accession 006095760

Section 7, Chapter 6096, Accession 006095761

Section 7, Chapter 6096, Accession 006095762

El Attar H., 1987: Pharmacokinetics of antituberculosis drugs in patients

Pudleiner P., 1987: Pharmacokinetics of apovincaminic acid in dogs

Section 7, Chapter 6096, Accession 006095765

Section 7, Chapter 6096, Accession 006095766

Section 7, Chapter 6096, Accession 006095767

Vane J.R., 1987: Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity

Section 7, Chapter 6096, Accession 006095769

Section 7, Chapter 6096, Accession 006095770

Section 7, Chapter 6096, Accession 006095771

Section 7, Chapter 6096, Accession 006095772

Jaakkola P., 1986: Pharmacokinetics of atropine in children

Section 7, Chapter 6096, Accession 006095774

Section 7, Chapter 6096, Accession 006095775

Section 7, Chapter 6096, Accession 006095776

Section 7, Chapter 6096, Accession 006095777

Section 7, Chapter 6096, Accession 006095778

Section 7, Chapter 6096, Accession 006095779

Section 7, Chapter 6096, Accession 006095780

Section 7, Chapter 6096, Accession 006095781

Hueller H., 1985: Pharmacokinetics of bendamustin cytostasan in patients

Houin G., 1987: Pharmacokinetics of bendazac lysine and 5 hydroxybendazac in patients with renal insufficiency

Forgione A., 1988: Pharmacokinetics of benperidol in volunteers after oral administration

Section 7, Chapter 6096, Accession 006095785

Section 7, Chapter 6096, Accession 006095786

Section 7, Chapter 6096, Accession 006095787

Sagarra R., 1987: Pharmacokinetics of besulpamide in rats and dogs

Section 7, Chapter 6096, Accession 006095789

Section 7, Chapter 6096, Accession 006095790

Section 7, Chapter 6096, Accession 006095791

Section 7, Chapter 6096, Accession 006095792

Section 7, Chapter 6096, Accession 006095793

Manzyuk L.V., 1984: Pharmacokinetics of bleomycetin an antitumor antibiotic in oncological patients treated with the drug using various methods of administration

Cederblad G., 1988: Pharmacokinetics of bolus intravenous and oral doses of l carnitine in healthy subjects

Bergan T., 1985: Pharmacokinetics of brodimoprim in serum and skin blister fluid

Taeuber U., 1987: Pharmacokinetics of bromerguride a new dopamine antagonistic ergot derivative in rat and dog

Section 7, Chapter 6096, Accession 006095798

Section 7, Chapter 6096, Accession 006095799

Olive G., 1984: Pharmacokinetics of buflomedil after intravenous administration in patients with chronic renal failure

Section 7, Chapter 6096, Accession 006095801

Section 7, Chapter 6096, Accession 006095802

Section 7, Chapter 6096, Accession 006095803

Section 7, Chapter 6096, Accession 006095804

Section 7, Chapter 6096, Accession 006095805

Section 7, Chapter 6096, Accession 006095806

Tillement J.P., 1984: Pharmacokinetics of butofilolol cafide after repeated oral administration in man

Cadorniga R., 1984: Pharmacokinetics of cadmium 109 in blood and cerebral structures of the rat

Section 7, Chapter 6096, Accession 006095809

Joshi A., 1988: Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothers

Skalkeas G., 1986: Pharmacokinetics of calcium dobesilate in beagle dogs after a single administration

Skalkeas G., 1986: Pharmacokinetics of calcium dobesilate in beagle dogs after repeated administration

Becker C.E., 1986: Pharmacokinetics of calcium sodium edta and chelation of lead in renal failure

Mechoulam R., 1988: Pharmacokinetics of cannabidiol in dogs

Section 7, Chapter 6096, Accession 006095815

Section 7, Chapter 6096, Accession 006095816

Kallay Z., 1988: Pharmacokinetics of carbisocaine in rats and mice

Manente P., 1986: Pharmacokinetics of carbocalcitonin in humans

Feindel W., 1985: Pharmacokinetics of carbon 11 labeled 1 3 bis 2 chloroethyl 1 nitrosourea in experimental brain tumor

Hoffmann H., 1987: Pharmacokinetics of carbon 14 ambazone in small laboratory animals

Arnold E., 1986: Pharmacokinetics of carbon 14 fenflumizole after intravenous administration to man

Section 7, Chapter 6096, Accession 006095822

Schulte K.E., 1984: Pharmacokinetics of carbon 14 labeled mofebutazone after oral administration in man

Section 7, Chapter 6096, Accession 006095824

Section 7, Chapter 6096, Accession 006095825

Section 7, Chapter 6096, Accession 006095826

Weenen, H.; Pinedo, H. M.; De-Planque, M. M.; Ten-Bokkel-Huinink, W. W.; Mcvie, J. G.; Lankelma, J., 1984: Pharmacokinetics of carminomycin in man biweekly schedule vs. single dose every 3 weeks

Section 7, Chapter 6096, Accession 006095828

Lebel M., 1988: Pharmacokinetics of carumonam after single and multiple 1 g and 2 g dosage regimens

Probst P.J., 1986: Pharmacokinetics of carumonam in patients with renal insufficiency

Kawada Y., 1987: Pharmacokinetics of cddp with sts and its effects on renal function

Ghezzi A., 1985: Pharmacokinetics of cefatrizine after oral administration in human volunteers

Section 7, Chapter 6096, Accession 006095833

Section 7, Chapter 6096, Accession 006095834

Section 7, Chapter 6096, Accession 006095835

Stoeckel K., 1988: Pharmacokinetics of cefetamet ro 15 8074 and cefetamet pivoxil ro 15 8075 after intravenous and oral doses in humans

Section 7, Chapter 6096, Accession 006095837

Section 7, Chapter 6096, Accession 006095838

Section 7, Chapter 6096, Accession 006095839

Section 7, Chapter 6096, Accession 006095840

Section 7, Chapter 6096, Accession 006095841

Section 7, Chapter 6096, Accession 006095842

Section 7, Chapter 6096, Accession 006095843

Section 7, Chapter 6096, Accession 006095844

Section 7, Chapter 6096, Accession 006095845

Section 7, Chapter 6096, Accession 006095846

Section 7, Chapter 6096, Accession 006095847

Section 7, Chapter 6096, Accession 006095848

Section 7, Chapter 6096, Accession 006095849

Section 7, Chapter 6096, Accession 006095850

Section 7, Chapter 6096, Accession 006095851

Section 7, Chapter 6096, Accession 006095852

Section 7, Chapter 6096, Accession 006095853

Section 7, Chapter 6096, Accession 006095854

Section 7, Chapter 6096, Accession 006095855

Section 7, Chapter 6096, Accession 006095856

Section 7, Chapter 6096, Accession 006095857

Section 7, Chapter 6096, Accession 006095858

Section 7, Chapter 6096, Accession 006095859

Section 7, Chapter 6096, Accession 006095860

Section 7, Chapter 6096, Accession 006095861

Section 7, Chapter 6096, Accession 006095863

Section 7, Chapter 6096, Accession 006095865

Section 7, Chapter 6096, Accession 006095866

Section 7, Chapter 6096, Accession 006095867

Section 7, Chapter 6096, Accession 006095868

Section 7, Chapter 6096, Accession 006095869

Section 7, Chapter 6096, Accession 006095870

Section 7, Chapter 6096, Accession 006095871

Section 7, Chapter 6096, Accession 006095872

Section 7, Chapter 6096, Accession 006095873

Allen H.R., 1984: Pharmacokinetics of cefpimizole in normal humans after single dose and multiple dose intravenous infusions

Section 7, Chapter 6096, Accession 006095875

Section 7, Chapter 6096, Accession 006095876

Section 7, Chapter 6096, Accession 006095877

Section 7, Chapter 6096, Accession 006095878

Section 7, Chapter 6096, Accession 006095879

Section 7, Chapter 6096, Accession 006095880

Section 7, Chapter 6096, Accession 006095881

Section 7, Chapter 6096, Accession 006095882

Section 7, Chapter 6096, Accession 006095883

Section 7, Chapter 6096, Accession 006095884

Section 7, Chapter 6096, Accession 006095885

Section 7, Chapter 6096, Accession 006095886

Section 7, Chapter 6096, Accession 006095887

Section 7, Chapter 6096, Accession 006095888

Section 7, Chapter 6096, Accession 006095889

Section 7, Chapter 6096, Accession 006095890

Section 7, Chapter 6096, Accession 006095891

Section 7, Chapter 6096, Accession 006095892

Section 7, Chapter 6096, Accession 006095893

Srivastava V.M.L., 1988: Pharmacokinetics of centperazine a new antifilarial agent

Section 7, Chapter 6096, Accession 006095895

Section 7, Chapter 6096, Accession 006095896

Section 7, Chapter 6096, Accession 006095897

Section 7, Chapter 6096, Accession 006095898

Yakovlev V.P., 1987: Pharmacokinetics of certain antibiotics in rats with infected inflammation

Kraml M., 1988: Pharmacokinetics of cetamolol in hypertensive patients with normal and compromised renal function

Norlander B., 1988: Pharmacokinetics of chloral hydrate poisoning treated with hemodialysis and hemoperfusion

Section 7, Chapter 6096, Accession 006095902

Section 7, Chapter 6096, Accession 006095903

Section 7, Chapter 6096, Accession 006095904

Warrell D.A., 1988: Pharmacokinetics of chloroquine in thais plasma and red cell concentrations following an intravenous infusion to healthy subjects and patients with plasmodium vivax malaria

Brown Awala E.E., 1986: Pharmacokinetics of chloroquine saliva and plasma levels relationship

Section 7, Chapter 6096, Accession 006095908

Section 7, Chapter 6096, Accession 006095909

Nielsen Kudsk F., 1985: Pharmacokinetics of chronic fluoride ingestion in growing pigs

Aogaichi K., 1986: Pharmacokinetics of cibenzoline after single and repetitive dosing in healthy volunteers

Baglin A., 1985: Pharmacokinetics of cibenzoline in patients with renal impairment

Section 7, Chapter 6096, Accession 006095913

Section 7, Chapter 6096, Accession 006095914

Section 7, Chapter 6096, Accession 006095915

Section 7, Chapter 6096, Accession 006095916

Section 7, Chapter 6096, Accession 006095917

Section 7, Chapter 6096, Accession 006095918

Section 7, Chapter 6096, Accession 006095919

Section 7, Chapter 6096, Accession 006095920

Section 7, Chapter 6096, Accession 006095921

Section 7, Chapter 6096, Accession 006095922

Section 7, Chapter 6096, Accession 006095923

Section 7, Chapter 6096, Accession 006095924

Section 7, Chapter 6096, Accession 006095925

Section 7, Chapter 6096, Accession 006095926

Section 7, Chapter 6096, Accession 006095927

Shurgot B., 1986: Pharmacokinetics of cis diamminedichloroplatinum ii after administration in hypertonic saline

Section 7, Chapter 6096, Accession 006095929

Sjovall J., 1985: Pharmacokinetics of clavulanic acid given in combination with amoxycillin in volunteers

Nanbo T., 1988: Pharmacokinetics of clearance in the maternal fetal amniotic fluid system of the rat

Section 7, Chapter 6096, Accession 006095932

Section 7, Chapter 6096, Accession 006095933

Section 7, Chapter 6096, Accession 006095934

Legler U.F., 1988: Pharmacokinetics of cloprednol in health volunteers

Section 7, Chapter 6096, Accession 006095936

Cautreels W., 1985: Pharmacokinetics of cm 57755 a new histamine h 2 receptor antagonist after single oral doses in man

Coppi G., 1988: Pharmacokinetics of co tetroxazine in volunteers after rectal administration

Crema A., 1987: Pharmacokinetics of co trimazine after single and multiple doses

Section 7, Chapter 6096, Accession 006095940

Prusova R.M., 1986: Pharmacokinetics of cobalt 57 bleomycetin a 5 in mice with lymphosarcoma lyo 1 under therapy with rubomycin

Section 7, Chapter 6096, Accession 006095942

Hempelmann G., 1986: Pharmacokinetics of continuous peridural morphine infusion

Batten J.C., 1987: Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis

Rowland M., 1987: Pharmacokinetics of cyclosporin influence of rate of constant intravenous infusion in renal transplant patients

Section 7, Chapter 6096, Accession 006095946

Renault H., 1988: Pharmacokinetics of cysteine ethyl ester in rat

Vinogradov V.A., 1988: Pharmacokinetics of dalargin

Section 7, Chapter 6096, Accession 006095949

Zaitseva T.M., 1988: Pharmacokinetics of deacetyllappaconitine

Paton W.D.M., 1986: Pharmacokinetics of delta 9 tetrahydrocannabinol in rabbits following single or multiple intravenous doses

Boneu B., 1988: Pharmacokinetics of dermatan sulfate in the rabbit after intravenous injection

Simon P., 1987: Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on hemodialysis

Simon P., 1988: Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis

Section 7, Chapter 6096, Accession 006095955

Section 7, Chapter 6096, Accession 006095956

Section 7, Chapter 6096, Accession 006095957

Section 7, Chapter 6096, Accession 006095958

Section 7, Chapter 6096, Accession 006095959

Section 7, Chapter 6096, Accession 006095960

Section 7, Chapter 6096, Accession 006095961

Section 7, Chapter 6096, Accession 006095962

Falletta J.M., 1985: Pharmacokinetics of diaziquone after three different dosage regimens

Martin G.R., 1985: Pharmacokinetics of dibekacin in children with cystic fibrosis

Henner W.D., 1986: Pharmacokinetics of dibromodulcitol in humans a phase i study

Section 7, Chapter 6096, Accession 006095966

Section 7, Chapter 6096, Accession 006095967

Hedner T., 1987: Pharmacokinetics of different epidural sites of morphine administration

Menzer R.E., 1984: Pharmacokinetics of diflubenzuron in 2 types of chickens

Section 7, Chapter 6096, Accession 006095970

Section 7, Chapter 6096, Accession 006095971

Section 7, Chapter 6096, Accession 006095972

Section 7, Chapter 6096, Accession 006095973

Section 7, Chapter 6096, Accession 006095974

Section 7, Chapter 6096, Accession 006095975

Jamali F., 1985: Pharmacokinetics of dipyrone in man role of the administration route

Wahlin Boll E., 1985: Pharmacokinetics of dixyrazine low bioavailability improved by food intake

Mico B.A., 1986: Pharmacokinetics of dopamine 2 agonists in rats and dogs

Giesing D.H., 1986: Pharmacokinetics of dothiepin in humans a single dose dose proportionality study

Section 7, Chapter 6096, Accession 006095980

Section 7, Chapter 6096, Accession 006095981

Section 7, Chapter 6096, Accession 006095982

Section 7, Chapter 6096, Accession 006095983

Section 7, Chapter 6096, Accession 006095984

Section 7, Chapter 6096, Accession 006095985

Section 7 , Chapter 6096, Accession 006095986

Section 7, Chapter 6096, Accession 006095987

Section 7, Chapter 6096, Accession 006095988

Section 7, Chapter 6096, Accession 006095989

Section 7, Chapter 6096, Accession 006095990

Section 7, Chapter 6096, Accession 006095991

De Gaetano G., 1987: Pharmacokinetics of enteric coated aspirin and inhibition of platelet thromboxane a 2 and vascular prostacyclin generation in humans

Tamsen A., 1987: Pharmacokinetics of epidural morphine and meperidine in humans

Section 7, Chapter 6096, Accession 006095994

Section 7, Chapter 6096, Accession 006095995

Section 7, Chapter 6096, Accession 006095996

Section 7, Chapter 6096, Accession 006095997

Section 7, Chapter 6096, Accession 006095998

Section 7, Chapter 6096, Accession 006095999


Submit PDF Full Text

No spam - Every submission is manually reviewed

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close